Hamps Bio, a company that recently had its IPO listing on the BSE SME platform, saw a stellar debut with its share price closing at a 99% premium over the IPO price. The IPO, which was subscribed 1057 times, had an issue price of ₹51 per share. The stock debuted at ₹96.90, a 90% premium over the IPO price, and closed at its upper circuit at ₹101.74.
The strong performance of Hamps Bio’s shares on the first day of trading signifies investor confidence in the company’s prospects. With such an impressive listing, it’s clear that the market has high expectations for Hamps Bio’s future growth and success.
Investors and analysts will be closely watching Hamps Bio’s performance in the coming days and weeks to see if the stock can maintain its momentum. The company’s strong debut has certainly put it on the radar of many market participants, and its future performance will be closely monitored by those looking to capitalize on its potential.
Overall, Hamps Bio’s IPO listing and subsequent share price performance have garnered significant attention in the market, and it will be interesting to see how the company fares in the days ahead. Stay tuned for more updates on Hamps Bio and other market developments as they unfold.
